Feed NEULANDLAB.NS
NE
Neuland Laboratories Limited
NEULANDLAB.NS · NSE
₹23,330.00 +0.53% (+₹123.00)
1M +24.37%
Market Cap ₹296.4B
P/E Ratio 81.42x
Div. Yield 0.15%
ROE 22.25%
Bulios Fair Price
₹18,238
21.8% downside
Preț actual
₹23,330
Subevaluat Valoare justă Supraevaluat
Potrivit Bulios Fair Price, acțiunile NEULANDLAB.NS sunt în prezent supraevaluate față de prețul lor de piață. Cum funcționează?
Valuation
7 /100
Expensive EV/EBITDA 51.49x
P/S 14.65x
P/B 15.81x
Growth
100 /100
Growing Rev. growth 20.34%
Book val. growth 23.54%
EPS growth 30.57%
Profitability
61 /100
Moderate Net margin 17.99%
Op. margin 23.86%
FCF margin 2.91%
Quality
87 /100
Excellent ROE 22.25%
ROA 12.42%
Asset turnover 0.69x
Debt
100 /100
Low Current ratio 2.09x
Int. coverage 20.16x
Net debt/EBITDA -0.09x
Stability
52 /100
Moderate Rev. volatility 24.33%
EPS volatility 48.50%
Profitable years 6
Întreabă StockBot despre NEULANDLAB.NS
Online
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
CEO
Davuluri Saharsh Rao
Employees
1,643
Headquarters
Hyderabad
Evenimente viitoare
10 NOV.
Earnings
Upcoming earnings report